NCT06843967 2026-03-13A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting54 enrolled
NCT05694871 2026-01-26Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated LiposarcomaAlliance for Clinical Trials in OncologyPhase 2 Active not recruiting77 enrolled